Or use of Psilocibinaa psychoactive compound found in the “magical mushrooms“More than doubled among adults in the United States in recent years, with a particularly notable increase among those who report Mental Health Problems.
The conclusion is from a new study published in the Journal of the American Medical Association (Jama) and released by the University of Colorado Anamchutz Medical Campus.
Researchers analyzed data from the National Drug and Health Use (NSDUH) survey and compared the use of psilocybin from 2015 to 2017 with the observed between 2020 and 2022. The results pointed out that use in the last year among adults jumped from 0.9% to 1.8%.
Growth was observed in several demographic groups, although the use remains higher among young adults (between 18 and 25 years old), according to the survey.
Supervised use and self -medication risks
One of the most significant indicators, according to the researchers, was the considerably higher use rate between individuals who reported having mental disorders.
The study identified that people with the highest in the last year, or other mental diseases have had substantially higher psilocybin use rates than those without these conditions.
Data indicate that a growing number of people may be using the substance in an attempt to self -medication.
“We found that since 2019, the number of people who use Psilocybin has increased sharply,” says researcher Karilynn Rockhill of Colorado School of Public Health, one of the study’s authors. “This seems to be in line with the time when some US states began to decriminalize or legalize it.”
The increase in use occurs in a context of changes in state and municipal laws in the United States, with several locations decriminalizing or legalizing psilocybin to supervised therapeutic use.
“Public opinion about psilocybin is changing. However, it means that we also need to ensure that people understand the risks, know how to use it safely, if they wish, and that health systems are prepared,” says researcher Joshua Black of the Rocky Mountain Rocky Mountain Control and safety center in Colorado.
Although research on the potential therapeutic benefits of psilocybin for conditions such as depression and stress are advancing, the study authors warn The risks of non -supervised use.
Researchers emphasize the importance of professional guidance, especially for individuals with pre -existing mental health conditions seeking relief outside a controlled clinical environment.
“If hospitals and public health systems do not see the complete panorama, they cannot respond properly,” adds Black. “Improved tracking and education tools are crucial as more states consider regulating or legalizing psilocybin.”
